ReviewBiomedicines2021
Primary Soft Tissue Sarcoma of the Heart: An Emerging Chapter in Cardio-Oncology.
Review in Biomedicines, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 19 citations in OpenAlex.
- Primary left atrial spindle cell sarcoma with low-grade malignant features mimicking recurrent myxoma: a case report.Journal of cardiothoracic surgery · 2026Article
- Primary malignant cardiac tumor of the left atrium masqueraded as multiple myxomas.Quantitative imaging in medicine and surgery · 2026Article
- Primary Mitral Valve Sarcoma Mimicking Infective Endocarditis.CASE (Philadelphia, Pa.) · 2026Article
- Surgical Management of Primary and Metastatic Cardiac Malignancies: A 20-Year Single-Center Experience.Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia · 2026Article
- Clinical characteristics and treatment outcomes of primary cardiac sarcomas: a retrospective analysis.Cardio-oncology (London, England) · 2025Article
- Primary cardiac angiosarcoma: A clinical report of 1 case and review of the literature.Medicine · 2025Review
- Case report: Cardiac myxoid fibrosarcoma: a report of two cases.Frontiers in oncology · 2025Article
- Case report: Primary cardiac synovial sarcoma with suspected connective tissue disease diagnosed by EBUS-TBMB.Frontiers in medicine · 2025Article
- Complete resection of a giant intrapericardial cardiac synovial sarcoma.Journal of cardiothoracic surgery · 2024Article
- Minimally-Invasive Approach in the Setting of a Malignant Primary Cardiac Tumor.The Thoracic and cardiovascular surgeon reports · 2024Article
- Genomic Landscape Comparison of Cardiac versus Extra-Cardiac Angiosarcomas.Biomedicines · 2023Article
- A case of cardiac tamponade caused by T4N2M1 lung squamous cell carcinoma invading the aorta.Forensic science, medicine, and pathology · 2023Article
- Dataset for the reporting of neoplasms of the heart, pericardium, and great vessels: recommendations from the International Collaboration on Cancer Reporting (ICCR).Virchows Archiv : an international journal of pathology · 2023Review
- Primary undifferentiated high-grade pleomorphic cardiac sarcoma in the left atrium with atypical presentation.BMJ case reports · 2023Article
- Genomic Characterization of Rare Primary Cardiac Sarcoma Entities.Diagnostics (Basel, Switzerland) · 2023Article
- Cardiac Sarcoma Presenting as Tamponade.Journal of community hospital internal medicine perspectives · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Primary malignant cardiac tumors are rare, with a prevalence of about 0.01% among all cancer histotypes. At least 60% of them are primary soft tissue sarcomas of the heart (pSTS-h) that represent almost 1% of all STSs. The cardiac site of origin is the best way to classify pSTS-h as it is directly linked to the surgical approach for cancer removal. Indeed, histological differentiation should integrate the classification to provide insights into prognosis and survival expectancy of the patients. The prognosis of pSTS-h is severe and mostly influenced by the primary localization of the tumor, the difficulty in achieving complete surgical and pharmacological eradication, and the aggressive biological features of malignant cells. This review aims to provide a detailed literature overview of the most relevant issues on primary soft tissue sarcoma of the heart and highlight potential diagnostic and therapeutic future perspectives.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.